Wanamaker

University of Phoenix Vice President of Data Strategy and Solutions named to The Global Data Power Women List by CDO Magazine

Retrieved on: 
Thursday, June 15, 2023
Professional Services, Education, Consumer, Data Analytics, Women, Continuing, University, Data management, Computing, University of Mumbai, Wanamaker, Business, Woman, MBA, Nayak, University of Phoenix, Organization, W. P. Carey School of Business, Machine learning, Artificial intelligence, Empowerment, Data science, Software, Management, Physics

University of Phoenix is pleased to share that Veena Nayak, vice president of data strategy and solutions for the University, was named to The Global Data Power Women List 2023 by CDO Magazine.

Key Points: 
  • University of Phoenix is pleased to share that Veena Nayak, vice president of data strategy and solutions for the University, was named to The Global Data Power Women List 2023 by CDO Magazine.
  • “I am honored to be included on The Global Data Power Women List 2023,” Nayak shares.
  • "We are immensely proud to celebrate the outstanding accomplishments of the women featured on the Global Data Power Women List 2023.
  • In her role as vice president of Data Strategy and Solutions at University of Phoenix, she leads the enterprise data strategy and data products family, developing innovative solutions in data management, governance and analytics using Artificial Intelligence and Machine Learning.

Proactive news headlines including Horizon Minerals, Stelar Metals, Prescient Therapeutics and Volt Resources

Retrieved on: 
Tuesday, October 25, 2022
Lithium, REE, C29, EMP, ASX, Diamond, VRC, Â, EMS, NASDAQ, Sempra Metals Ltd v IRC, IPO, Patient, Proactivity, XETRA, JRL, Initial public offering of Facebook, Patrick Yandall, CSPG, PLL, MXC, PTX, LIB, LSE, OTC, Gold, GLOBE, Iroquois, Piedmont Lithium, QML, HRZ, Wanamaker, TCL, AVL, Rare-earth element, Mining, Central West (New South Wales)

Click here

Key Points: 
  • Click here
    Emperor Energy Ltd (ASX:EMP) has added A$1.12 million to the company coffers thanks to a strongly supported placement.
  • Click here
    Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Proactive news headlines including Westar Resources, Race Oncology, Cobalt Blue Holdings and Medibank Private

Retrieved on: 
Monday, October 17, 2022
Well, Lithium, ACT, Rare-earth element, Therapy, Conference, PNR, Program, OTC, First Nations, LNR, QML, RAC, CPV, Immunoglobulin G, Gene editing, Pitt Street, Wanamaker, GLOBE, Animal, AusIndustry, Sempra Metals Ltd v IRC, Demonstration plant, PAB, Lac Minerals Ltd v International Corona Resources Ltd, Lyon, China Beijing International Mining Exchange, OTCQB, Mining, Norseman Gold Mine, EMS, Capital districts and territories, ASX, Proactivity, CXO, ARN, SAU, Aborigine, Acquisition, AVL, Management, Renewable energy, Fraser Range, International Convention Centre Sydney

Click here

Key Points: 
  • Click here
    Cobalt Blue Holdings Ltd (ASX:COB, OTC:CBBHF) is making positive progress with processing ore from the Broken Hill Cobalt Project (BHCP) into concentrate for use in its Demonstration Plant to provide bulk samples for potential commercial partners of high-value cobalt products.
  • Click here
    Medibank Private Ltd (ASX:MPL) has resumed trading after its shares were placed in a trading halt following a cyber incident that occurred on its networks last Wednesday.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Proactive news headlines including Dart Mining, MGC Pharmaceuticals, Taruga Minerals and Evolution Energy Minerals

Retrieved on: 
Wednesday, September 21, 2022
BHA, Molybdenum, Proactivity, Patient, OTC, Granite Flats, Medical Research Council, VAT, APC, ASX, COVID-19, Chartered accountant, IMU, Acquisition, BRU, IP, Imperial College London, Copper, DSF Refractories & Minerals Ltd, BSX, MXC, Infection, ESG, Ravensthorpe, Gold Bridge, News, SOP, OTCQX, LSE, NIS, NCP, CCZ, Biophysical environment, RAD, Meteoroid, MAST, GLOBE, Social Security Government Pension Offset, Amax Potash Ltd v Saskatchewan, MRE, Burracoppin, Western Australia, Athabasca Basin, National Health and Medical Research Council, VRC, Silver, TGC, REE, Plant, Social, KCB, Wanamaker, DTM, Mining, Pharmaceutical industry, Rare-earth element, Oil, Uranium, Lithium

Click here

Key Points: 
  • Click here
    Buru Energy Ltd (ASX:BRU) has welcomed Chartered Accountant and governance professional Paul Bird to the team as chief financial officer, effective October 10, 2022.
  • Click here
    Triangle Energy (Global) Ltd has secured 100% of two key onshore Perth Basin permits, L7 and EP 437, from Key Petroleum Ltd (ASX:KEY).
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Tevogen Bio Establishes Philadelphia R&D Center to Expedite Product Development in Oncology, Neurology, and Virology

Retrieved on: 
Thursday, June 30, 2022
Neurology, Surgery, Other Health, Other Science, Pharmaceutical, Research, Oncology, Mental Health, Medical Devices, Infectious Diseases, Hospitals, Genetics, Fitness & Nutrition, Clinical Trials, Cardiology, Stem Cells, Science, Biotechnology, Practice Management, Nursing, Managed Care, Medical Supplies, AIDS, General Health, FDA, Health, Diabetes, Thomas Jefferson University Hospital, Cell, Malignancy, Patient, Bio, Korea Carbon Capture & Sequestration R&D Center, Research, State Farm Research and Development Center, Laboratory, COVID-19, Company, Degenerative disease, Terminology, Development, Toxic shock syndrome, Virology, CRS, CIC, Neurology, Cancer, Clinical trial, Center, Cytokine release syndrome, Virus, CTL, Medicine, Wanamaker, The Center, Multimedia, Forward-looking statement, Vaccine, Fine chemical

View the full release here: https://www.businesswire.com/news/home/20220630005760/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220630005760/en/
    Tevogen Bio establishes R&D Center in Philadelphias Wanamaker Office Building to expedite product development in oncology, neurology, and virology.
  • (Photo: Business Wire)
    The Center will serve as the central location for the companys product development initiatives and will house Tevogens Global R&D Leadership Team.
  • The Wanamaker location accompanies Tevogens recently announced CIC Philadelphia facilities which will provide the company with comprehensive research and product development capability.
  • The companys lead product, TVGN-489, is currently in clinical trial for high-risk COVID-19 patients at Jefferson University Hospitals in Philadelphia.